Preventing venous thromboembolism in general medical inpatients and after an ischaemic stroke

Haemostasis

Volumn 30, Issue SUPPL. 2, 2000, Pages 64-71

  Gallus, Alexander A S ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

General medical inpatients; Ischaemic stroke; Prevention of venous thromboembolism

Indexed keywords

CERTOPARIN; DALTEPARIN; DANAPAROID; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; HOSPITAL PATIENT; HUMAN; LUNG EMBOLISM; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; VEIN THROMBOSIS;

EID: 0034462607     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054166     Document Type: Conference Paper

References (33)

1. Incidence of deep vein thrombosis in bedridden non-surgical patients
2. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism
3. Incidence of venous thromboembolism: A community-based study in Western France
4. Incidence of venous thromboembolism verified by necropsy over 30 years
5. 178 Fatal cases of pulmonary embolism in a medical department
6. Prevention of venous thromboembolism
7. Prevention of deep vein thrombosis in medical patients by low dose heparin
8. Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: A randomized double-blind trial
9. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients
10. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: A meta-analysis of randomised clinical trials
11. Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis
12. Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases
13. The influence of CY 216 administration on hospital mortality of general medical in-patients. International collaborative double-blind study: Methods and preliminary results
14. Heparin prophylaxis in bedridden patients
15. Low molecular weight heparin in the prevention of perioperative thrombosis
16. Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients
17. Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical patients
18. The venous thrombotic risk in non-surgical patients: Epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin)
19. Low dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke
20. Low-dose subcutaneous heparin in the prevention of deep vein thrombosis and pulmonary emboli following acute stroke
21. Prophylaxis of deep vein thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients
22. Double blind randomised trial of Org 10172 low molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke
23. Anticoagulants for acute ischaemic stroke
24. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke
25. The International Stroke Trial (IST) A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke
26. Low molecular weight heparin, Org 10172 (danaparoid) and outcome after acute ischemic stroke
27. Fraxiparine in Ischaemic Stroke Study (FISS bis)
28. A multi-center randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness
29. Study to compare the efficacy and safety of the LMWH enoxaparin and standard heparin in the prevention of thromboembolic events in medical patients with cardiopulmonary disease
30. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep vein thrombosis in acute ischemic stroke
31. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study
32. A multi-centre double blind randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low dose heparin in preventing deep-vein thrombosis in patients with acute ischemic stroke
33. Enoxaparin, a low-molecular weight heparin (LMWH) may be superior to standard heparin in the prevention of deep vein thrombosis (DVT) in stroke patients